| 000 | 007650000a22002170004500 | ||
|---|---|---|---|
| 008 | 110822t xxu||||| |||| 00| 0 eng d | ||
| 020 | _a1 74186 166 7 | ||
| 040 | _cVAD | ||
| 041 | _aEngels | ||
| 110 | _aNational Drug Strategy | ||
| 245 | _aNational clinical guidelines and procedures for the use of buprenorphine in the treatment of opioid dependence [PDF] | ||
| 260 |
_aCanberra _bCommonwealth of Australia _c2006 |
||
| 300 | _aIX, 71 p. | ||
| 650 | _aAustralië | ||
| 650 | _adrugs | ||
| 650 | _aheroïne | ||
| 650 | _ahulpverlening | ||
| 650 | _abuprenorfine | ||
| 650 | _abehandelrichtlijnen | ||
| 856 | _uhttp://www.google.com/search?q=National-clinical-guidelines-and-procedures-for-the-use-of-buprenorphinen in the treatment of opioid dependence | ||
| 999 |
_c15619 _d15619 |
||